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Abstract
A burst in the production of pro-inflammatory molecules characterizes the beginning of the host response to infection.
Cytokines, chemokines, and growth factors work in concert to control pathogen replication and activate innate and
adaptive immune responses. Granulocyte colony-stimulating factor (G-CSF) mobilizes and activates hematopoietic cells
from the bone marrow, and it has been shown to mediate the generation of effective immunity against bacterial and fungal
infections. G-CSF is produced at high levels in the lungs during infection with influenza and parainfluenza viruses, but its
role during these infections is unknown. Here we show that during infection of mice with a non-lethal dose of influenza or
Sendai virus, G-CSF promotes the accumulation of activated Ly6G
+ granulocytes that control the extent of the lung pro-
inflammatory response. Remarkably, these G-CSF-mediated effects facilitate viral clearance and sustain mouse survival.
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Introduction
Infection of mice with either the murine parainfluenza virus
Sendai (SeV) or mouse adapted influenza A virus triggers robust
production of pro-inflammatory molecules in the respiratory tract.
This cytokine burst is followed by massive infiltration of
neutrophils, monocytes, NK cells, DCs and other cell types to
the lung. Cytokines and infiltrating cells play a critical role in the
clearance of the infection and in the initiation of adaptive
immunity [1,2,3]. In addition, cytokines produced in the infected
lung are transmitted systemically through the blood to alert bone
marrow (BM) leukocytes of the presence of the virus, and to
condition them to better fight the infection [2].
G-CSF is found in high levels in the lung and blood of mice
infected with influenza or parainfluenza virus [2]. G-CSF plays a
major role in the mobilization and activation of neutrophils and
other myeloid cells from the BM [4,5] and is currently used to
promote mobilization of BM cells in different clinical settings
[6,7,8]. G-CSF receptor- deficient mice are severely neutropenic
and show altered responses to bacterial and fungal infections
[9,10,11,12]. However, the role of G-CSF during respiratory viral
infection has not been directly evaluated. Here we show that G-
CSF regulates lung inflammation during viral infection and that
this cytokine is critical for the survival of the host during infection
with influenza or the murine parainfluenza virus Sendai.
Materials and Methods
Mice and viruses
Age and sex-matched mixed background G-CSF
2/2
(B6;129P2-Csf3tm1Ard/J) [9] and control mice of the best
approximate mixed background (B6129PF2/J) from The Jackson
Laboratory were used in most experiments. G-CSF
2/2 mice
backcrossed to C57BL/6 mice for 7 generations were used where
indicated. Mice were bred and housed in pathogen-free conditions
and the experiments were performed according to institutionally
approved protocols (specific approvals for this project were
obtained from the Institutional Animal Care and Use Committees
of The Mount Sinai School of Medicine (#08-0160) and The
University of Pennsylvania (#803173)). SeV strain 52 and
influenza virus strains PR8 (A/PR/8/1934 (H1N1)) and 631
(A/HK631 (H3N2)) were grown in 10-day embryonated chicken
eggs (SPAFAS; Charles River Laboratories). Allantoic fluid was
snap frozen in an ethanol-dry ice bath and stored at 280uC.
Mice infection and lung virus titration
Infections with SeV strain 52 were performed in anesthetized
mice via intranasal inoculation of 10
4 infectious viral particles in
35 ml of PBS. This dose was previously determined in our
laboratory to reliably establish non-lethal infections [3,13,14].
Influenza virus infections were performed via aerosol by placing
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Corp, Model A4212) utilizing a nebulization-infection cycle of
30 min. Influenza virus strain PR8 was aerosolized at a
concentration of 10
8 virus particles in 12 ml PBS. Influenza virus
631 was aerosolized at a concentration of 10
9 virus particles in
12 ml PBS. Nebulization was achieved at a vacuum of 30 standard
cubic feet per hour (SCFH) and compressed air flow of 15 SCFH.
The chamber was UV-decontaminated in between viruses. Under
these conditions, 100% of the animals were infected and showed
reproducible lung titers in several experiments at every time point
analyzed. Virus titers were determined by infecting permissive cell
lines LLCMK2 (ATCC; CCL-7.1) (SeV) or MDCK (influenza) [2]
with serial dilutions of lung homogenates in the presence 2 mg/ml
of trypsin for 72 h at 37uC. Supernatants were tested by
hemagglutination of chicken RBCs (Lampire) for the presence of
virus particles.
rhG-CSF injections
250 mg/kg rhG-CSF (Neupogen/Filgrastim, AMGEN, Thou-
sand Oak, CA) [15] or distilled sterile water was injected IP daily
to G-CSF
2/2 mice starting four days before infection. Some mice
continued to receive rhG-CSF injections daily for the duration of
the experiment.
Figure 1. Vital role for G-CSF produced in the lung of infected mice. (A) G-CSF measured in the sera of mice 3 days after infection with SeV or
with influenza virus 631 (IAV). (B) Percent weight change of G-CSF
+/+ and G-CSF
2/2 mice infected with SeV (n=6), influenza 631 (n=7) or mock
treated controls. P.0.6 two-way ANOVA for infected groups. (C) Survival of G-CSF
+/+ and G-CSF
2/2 mice monitored after infection with SeV (n=6,
p=0.0009, logrank test) or influenza631 (n=7, p=0.012, logrank test). (D) SeV titer in the lungs of G-CSF
+/+ and G-CSF
2/2 mice at the indicated time
points (n=8). (E) Viral titers in the lungs of G-CSF
2/2 mice infected with SeV and treated with daily injections of H2O or rhG-CSF four times before
infection (Before) or continued treatment throughout the course of the experiment (Daily). ND: non-detected, NM: non-measured. Asterisks indicate p
values. Data presented is representative of more than two independent experiments.
doi:10.1371/journal.pone.0037334.g001
G-CSF in Respiratory Viral Infections
PLoS ONE | www.plosone.org 2 May 2012 | Volume 7 | Issue 5 | e37334In vivo neutrophil depletion
Mice were injected intraperitoneally with 400 mg/mouse of an
isotype control (2A3) or with rat anti-lymphocyte antigen 6
complex, locus G (Ly6G) antibody (1A8; BioXCell, West
Lebanon, NH). Antibody injections were performed at 24 and
0 h prior to infection and every 48 h thereafter.
Flow cytometry
Lungs were flushed with cold PBS containing 0.5 mM EDTA
prior to grinding and digestion with collagenase (Liberase
Blendzymes, Roche, Indianapolis, IN). Blood was collected with
heparinized capillary tubes. BM was flushed with ice-cold PBS.
Erythrocytes were eliminated from the lung, blood, and BM
samples using RBCs lysis buffer (BD Biosciences). Single-cell
suspensions were incubated with anti-mouse CD16/32 (BD
Biosciences) for 10 min at 4uC. The following antibodies from
BD Biosciences or eBioscience were used for staining: B220 (RA3-
6B2), CD3 (145-2C11), CD4 (GK1.5), CD8a (53-6.7), CD19
(1D3), NK1.1 (PK136), Ter119, CD11b (M1/70), CD11c (HL3),
CD45.2 (104), CD115 (AFS98), Ly6C (AL-21), Gr-1 (RB6-8C5)
Ly6G (1A8). mPDCA-PE (JF05-1C2.4.1) was obtained from
Miltenyi Biotec.
Cytokine detection in serum and lung
Whole lung was ground in 1.8 ml 0.01% gelatin/PBS. Cytokine
concentration was analyzed by multiplex ELISA (Milipore). G-
CSF concentration was measured by ELISA (R&D).
Detection of virus specific antibodies
ELISA plates were coated with purified SeV (5 mg/ml)
overnight. Plates were blocked with PBS/BSA for 2 h. Dilutions
of lung homogenate from infected and non-infected mice were
incubated overnight at 4uC. SeV specific antibodies of different
isotypes were detected by peroxidase-conjugated goat anti-mouse
antibodies (Jackson ImmunoResearch).
In vivo cytotoxic T lymphocyte (CTL) assay
Splenocytes from naive mice were pulsed with 20 mg/ml SeV
NP324–332 peptide or with 20 mg/ml influenza PR8 NP(366–374)
peptide in PBS as previously described [14].
In vivo phagocytosis assay
Yellow-green fluorescent latex particles (10 mm, Polysciences) or
unlabeled particles were diluted 1:20 in PBS and 30 ml of the
dilution was administered intranasally to anesthetized mice. Mice
were sacrificed 4 h later and bead uptake by lung leukocytes was
analyzed by flow cytometry.
Histology and bronchoalveolar lavage (BAL) analysis
BAL was obtained after one cycle of infusion and aspiration into
the lungs of 1 ml of sterile saline as previously described [16]. Cell
pellets obtained after BAL centrifugation at 400 g were suspended
in 500 ml of PBS and counted manually for total cell counts (TLC).
Cell-free BAL was aliquoted and frozen until further analysis.
Total protein in BAL was measured by the Coomasie blue
spectrophotometric assay (Bio Rad) using BSA dilutions as
standards. After lavage, the left lobe of the lung was inflation-
fixed with 0.5 ml of 10% neutral buffered formalin for histological
analysis. Paraffin sections from fixed lungs were stained with
hematoxylin and eosin and scored on the basis of presence and
absence of peribronchiolar and alveolar infiltration, vascular
congestion and alveolar edema [17].
Enrichment of Ly6G
+ cells from bone marrow
Bone marrow from femur and tibia of WT and G-CSF
2/2
mice was flushed out with serum-free DMEM (Invitrogen)
Figure 2. G-CSF regulates the lung inflammatory response during virus infection. (A–B) Cytokine secretion in the lungs of G-CSF
2/2 and G-
CSF
+/+ mice infected with SeV was measured by multiplex ELISA (n=4).
doi:10.1371/journal.pone.0037334.g002
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+ cells were enriched by
positive selection using magnetic beads. Non-specific antibody
binding on cells was blocked using anti-CD16/CD32. Up to
1610
8 bone marrow cells were incubated on ice for 15 min with
biotin-anti Ly6G antibody (1A8, Biolegend), followed by incubation
with anti-biotin microbeads (Miltenyi Biotech). An enrichment
column was used per manufacturer’s instructions to collect Ly6G
+
and Ly6G
2 fractions. The separated fractions were spun at 400 g
for 10 min and the cell pellets suspended in Trizol (Invitrogen) for
RNA extraction and qPCR analysis. A sample of each sample was
analyzed by cytospin, confirming a .95% enrichment of polymor-
phonuclear cells in the Ly6G
+ fraction (not shown).
Quantitative RT-PCR
RNA was extracted from BMDCs, lung fibroblasts, and RAW
264.7 cells at the indicated time points after virus infection using
TRIzol (Invitrogen Life Technologies) or the High Pure RNA
Isolation Kits (Roche). RNA was measured and equivalent
amounts of RNA from each sample (0.5–1.0 mg) were reverse
transcribed using the High Capacity RNA-to cDNA Kit (Applied
Biosystems). cDNA was diluted to a concentration of 10 mg/ml min
distilled water, and PCR reactions were performed in triplicate
using specific primers and the Power SYBRH Green PCR Master
Mixture (Applied Biosystems). Normalization was conducted
based on levels of a-tubulin and rps11. The following primer
sequences were used: a-tub: for-59TGCCTTTGTGCACTGG-
TATG39 rev-59CTGGAGCAGTTTGACGACAC39, rps11: for-
59CGTGACGAAGATGAAGATGC39 rev- 59GCACATTGAA-
TCGCACAGTC39, ela-2: for- 59TGGAGGTCATTTCTG-
TGGTG39 rev- 59CTGCACTGACCGGAAATTTAG39, mpo:
for-59 CAAGGCCTTTCAATGTTACAGA39 rev-59TGTC-
ACCCTCACGTCCTG39, cebp-beta: for-59ATCGACTTCAGC-
CCCTACCT39 rev-59TAGTCGTCGGCGAAGAGG39, Il-10:
for-59TGTCCAGCTGGTCCTTTGTT39 rev-59ACTGCACCC-
ACTTCCCAGT39, ccl-5: for-59GCAGCAAGTGCTCCAAT-
CTT39 rev-59CAGGGAAGCGTATACAGGGT39 (applied bio-
system, Viia7).
Statistical analysis
Results are expressed as means 6 s.d. Statistical significance was
determined by two-tailed Student’s t test unless otherwise
indicated. Values of at least p,0.05 were considered significant.
Results
G-CSF produced during infection with SeV or influenza
virus promotes host survival and viral clearance
As reported earlier [2], high levels of G-CSF can be detected in
the lung and serum of mice infected with influenza or SeV
(Figure 1A). To assess the role of G-CSF during respiratory virus
infection, mixed background G-CSF
+/+ and G-CSF
2/2 mice were
infected with mouse adapted influenza virus or with SeV. G-
CSF
+/+ and G-CSF
2/2 infected mice lost weight at a similar rate
after infection regardless of the virus (Figure 1B); strikingly, in the
absence of G-CSF all mice succumbed to the infection between
days 7 and 10 after infection (Figure 1C). These data highlight an
essential role for G-CSF in protecting the host from death during
infection with normally non-lethal respiratory viruses.
To further characterize the protective role of G-CSF during
respiratory viral infection, we focused on infections with SeV, a
natural mouse pathogen. To define whether G-CSF affects viral
load, we compared viral titers in the lungs of infected G-CSF
+/+
and G-CSF
2/2 mice. SeV replicated equally well in the lungs of
G-CSF
+/+ and G-CSF
2/2 mice in the days that follow infection.
However, while G-CSF
+/+ mice cleared SeV by day eight-post
infection, virus was still found in the lungs of G-CSF
2/2 at this
time point (Figure 1D). Administration of daily doses of
Figure 3. Adaptive immunity in the absence of G-CSF. (A) SeV
specific antibodies in lung homogenate of G-CSF
+/+ and G-CSF
2/2 mice
measured by ELISA 7 days after infection (n=4). Experiment shown is
representative of two independent experiments. IgG2a p.0.15, IgG3
p.0.07, IgG2b p,0.006, total IgG p,0.03 between infected G-CSF
+/+
and infected G-CSF
2/2 for all dilutions. (B) Mock and SeV infected G-
CSF
+/+ or G-CSF
2/2 mice were injected i.v. 7 days after infection with
CFSE-labeled peptide-pulsed splenocytes. Splenocytes labeled with a
high dose of CFSE were pulsed with SeV NP peptide and those labeled
with a low dose of CFSE were pulsed with the irrelevant influenza virus
(PR8) NP peptide. Empty histograms show CFSE staining on mock-
infected animals 24 h after injection of labeled/pulsed splenocytes.
Filled histograms correspond to CFSE staining on SeV infected mice
24 h after injection of labeled/pulsed splenocytes (n=4 per group).
Experiment shown is representative of two independent experiments.
(C) Survival of G-CSF
+/+ and G-CSF
2/2 mice infected with a sublethal
dose of influenza virus 631 or mock treated and challenged at day 19
with a normally lethal dose of influenza virus PR8. Survival was
monitored daily (n=14/16 mice in 631 challenged groups, n=5 in
mock treated controls). Experiment shown is representative of two
independent experiments.
doi:10.1371/journal.pone.0037334.g003
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infection improved the ability of G-CSF
2/2 mice to control virus
replication (Figure 1E), confirming an essential role of G-CSF for
efficient viral clearance.
G-CSF deficient mice show increased production of pro-
inflammatory molecules in the lung during infection
To determine whether the lung anti-viral response was altered
in G-CSF
2/2 mice, we profiled the production of pro-inflamma-
tory cytokines in the lungs at different times after infection with
SeV (Figures 2A). G-CSF
2/2 mice showed higher levels of pro-
inflammatory molecules including cytokines (IL-6, TNF, IFNc)
and chemokines (CCL2, CXCL1, CCL5) compared with control
mice. The differences in pro-inflammatory molecules were most
evident at day 8 post-infection correlating with the sustained
presence of virus in G-CSF
2/2 mice at this time point (Figure 1D).
Remarkably, in contrast to all other cytokines analyzed, the
mRNA and protein levels of IL-1b were significantly reduced in
Figure 4. G-CSF regulates the cellular infiltrate during virus infection. (A) Cell numbers in the lungs of SeV infected mice calculated at the
indicated time points from total cell counts and flow cytometry analysis. Populations were identified with the following markers: neutrophils
(CD11b
+Ly6c
+Ly6G
+), monocytes (CD11b
+Ly6C
+Ly6G
2), pDCs (CD11b
2B220
+mPDCA
+), CD4
+ T cells (CD3
+CD4
+CD8
2), CD8
+ T cells (CD3
+CD8
+CD4
2),
and NK cells (CD11b
+NK1.1
+). Pre-gated on PI
2CD45
+ cells. Error bars represent standard deviation from the mean. Asterisks indicate p values (n=3).
(B) Ly6G
+ granulocytes in the lung, BM and blood of G-CSF
2/2 and G-CSF
+/+ mice mock treated or infected with SeV for 4 days. Pre-gated on
PI
2CD45
+CD11b
+ cells. Results are representative of more than two independent experiments.
doi:10.1371/journal.pone.0037334.g004
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2/2 mice at day 5 post-infection (Figure 2B and data not
shown).
G-CSF deficient mice develop adaptive immune
responses against the virus
We next evaluated the effect of G-CSF on the development of
adaptive immunity against the virus. G-CSF deficient mice
generated SeV specific antibodies, although anti-viral antibodies
of the IgG2b isotype were significantly reduced (Figure 3A). The
absence of G-CSF did not affect the development of effector
cytotoxic T lymphocytes (CTLs) as evidenced by efficient killing of
specific target cells in vivo (Figure 3B). To evaluate whether G-CSF
deficient mice developed protective cellular immunity, we utilized
a well-characterized model of heterosubtypic infection with
influenza virus [18]. G-CSF
2/2 mice infected with a sub-lethal
dose of influenza strain 631 (H3N2) were protected against
challenge with a normally lethal dose of the heterosubtypic
influenza strain PR8 (H1N1) (Figure 3C) that is not susceptible to
neutralization by anti-X31 antibodies. These data indicate that the
presence of G-CSF determines the quality of the initial inflam-
matory response to respiratory viruses but has minimal effects on
the development of anti-viral adaptive immune responses.
G-CSF deficient mice show reduced cellular infiltrate and
tissue damage during infection
We next analyzed the composition of the lung cellular infiltrate
during infection. The numbers of infiltrating monocytes and
plasmacytoid DCs in the lung of mock and infected mice were not
significantly different in the absence or presence of G-CSF
(Figures 4A). NK cells were transiently reduced in the lung of G-
CSF
2/2 mice at early times after infection but this trend did not
reach statistical significance. Notably, CD8
+ T cells were elevated
on day 8 after infection in G-CSF
2/2 mice, possibly in response to
higher virus titers compared to controls at this time point. As
expected [9], mock-infected G-CSF
2/2 mice had lower levels of
Ly6G
+ granulocytes in the BM, blood, and lung compared to G-
CSF
+/+ mice. Despite an increase in the number of granulocytes in
the lung during infection with SeV, these cells were significantly
lower in the lung of G-CSF
2/2 mice compared to controls at all
time points analyzed (Figures 4A and B).
Reduced cellular infiltration to the lung of G-CSF
2/2 mice was
also apparent in the analysis of the BAL of infected mice. Total
lymphocytes (TLC) in the BAL were significantly reduced in
infected G-CSF
2/2 and G-CSF
+/2 mice compared to infected G-
CSF
+/+ controls (Figure 5A). Histological analysis of the lung
showed marked peribronchiolar and alveolar infiltration of cells
post-infection in WT mice, which was significantly attenuated in
similarly infected G-CSF
2/2 mice (Figure 5B). However, 25–30%
higher levels of total protein were observed in BAL of G-CSF
2/2
mice after infection (963 mg/ml in WT vs. 1207 mg/ml in G-
CSF
2/2 mice; data not shown), suggesting partial loss of
bronchoalveolar-epithelial integrity in mice deficient in G-CSF.
Importantly, the experiments in Figure 5 were performed in G-
CSF
2/2 mice backcrossed to the C57BL/6 background, demon-
strating that the protective phenotype observed in mice with mixed
genetic background is maintained in the more resistant C57BL/6
mouse strain.
Reduced numbers of activated Ly6G
+ granulocytes are
present in the lungs of G-CSF deficient mice
To evaluate the effect of G-CSF in the activation status of
Ly6G
+ granulocytes during virus infection, we analyzed the
expression of genes associated with neutrophil activation in Ly6G
+
granulocytes of G-CSF
2/2, G-CSF
+/2, and G-CSF
+/+ mice 4
days after infection. To avoid potential confounding effects of
direct virus infection of granulocytes in the lung, we analyzed
granulocytes residing in the distal bone marrow of the infected
mice, as we have shown that these cells respond to cytokines
produced by the lung during infection [2]. As shown in Figure 6A,
G-CSF induced the expression of a number of genes associated
with neutrophil activation (elastase, Ela-2; myeloperoxidase, MPO
and C/EBPb) in bone marrow Ly6G
+ cells of WT mice.
Unexpectedly, the regulatory cytokine IL-10 was also expressed
at high levels in Ly6G
+ cells from infected WT mice. Expression of
all these genes was severely impaired in Ly6G
+ cells from G-
CSF
2/2 and G-CSF
+/2 mice, suggesting a critical role of G-CSF
in generating a functionally active population of Ly6G
+ granulo-
Figure 5. G-CSF deficiency reduces lung infiltrate during virus infection. (A) Total cell counts in cytospins made with bronchoalveolar
lavage (BAL) 8 days after infection with SeV. (B) Representative pictures of H&E-stained lung sections from naive and SeV infected G-CSF
+/+ and G-
CSF
2/2 C57BL/6 mice.
doi:10.1371/journal.pone.0037334.g005
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kine CCL5 was not different in WT and G-CSF
2/2 suggesting
that the hyporesponsiveness in SeV-infected Ly6G
+ cells is
restricted to granulocyte-specific genes.
We next examined whether the phagocytic ability of neutrophils
recruited to the lung during infection was altered in G-CSF
2/2
mice. To test this, G-CSF
2/2 and G-CSF
+/+ mice were infected
with SeV and four days later fluorescently labeled latex beads were
administered intranasally [19]. We measured the efficiency of bead
phagocytosis by granulocytes using flow cytometry. Figure 6B
shows that despite a severe reduction in the number of phagocytic
granulocytes in the lung of G-CSF
2/2 mice, there is an equal
percentage of bead positive cells within granulocytic populations of
G-CSF
2/2 and G-CSF
+/+ mice. These data indicate that the
virus-activated phagocytic ability of granulocytes is unaffected by
the presence or absence of G-CSF, although the number of
activated phagocytic cells present in the lung of G-CSF
2/2 mice is
significantly reduced.
To test whether a reduction of the number of granulocytes
recapitulates the enhanced pathology observed in the absence of
G-CSF, we used an anti-Ly6G antibody to deplete Ly6G
+ cells
from WT mice [20,21]. Granulocyte counts were reduced by 70%
in the blood of WT mice twenty-four hours after a single dose of
anti-Ly6G antibody (Figure 6C) mimicking the percent reduction
of granulocytes in the blood of G-CSF
2/2 mice compared to WT
controls (Figure 4B). Similar to G-CSF
2/2 mice, depletion of
Ly6G
+ cells from WT mice resulted in a weight loss comparable to
that of control mice (Figure 6D), but also resulted in enhanced
mortality post-infection (Figure 6E).
Together with the observed dramatic reduction in the
expression of functional genes, these data suggest a critical role
for activated Ly6G
+ granulocytes in the G-CSF-mediated protec-
tion from death during respiratory viral infections.
Discussion
We have shown that the absence of G-CSF results in decreased
survival of the host during a respiratory tract viral infection
(Figure 1) independently of the generation of cellular and humoral
adaptive immunity (Figure 3). G-CSF regulates mobilization of
Figure 6. Activated Ly6G
+ granulocytes protect from mortality during virus infection. (A) Cytokine gene expression in Ly6G
+ enriched
bone marrow cells. (B) Uptake of fluorescent latex beads by neutrophils (PI
2CD45
+Ly6G
+CD11b
+) in the lung of GCSF
+/+ and G-CSF
2/2 mice four days
after infection with SeV (n=4). (C) Representative flow cytometry analysis of neutrophils (CD11b
+Ly6c
int) and monocytes (CD11b
+Ly6c
hi) in the blood
of mice injected with a single dose of anti-Ly6G antibody (1A8) or an isotype control. Neutrophil depleted WT C57BL6 mice were infected with SeV
and monitored for (D) weight loss (p.0.9 two way ANOVA for infected groups) and (E) survival (n=10 for isotype treated, SeV infected and n=20 for
Ly6G depleted and SeV infected. Logrank test, p,0.0001). Experiments shown are representative of two or three independent experiments.
doi:10.1371/journal.pone.0037334.g006
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from the BM [5,22] and plays a critical role in the activation of
neutrophils that control bacterial and fungal infections
[9,10,11,12]. In the present work we demonstrated that G-CSF
regulates the outcome of respiratory viral infections by stimulating
the mobilization and recruitment of large numbers of activated
granulocytes to the infected lung, thereby promoting viral
clearance and eliciting a distinct survival advantage.
Neutrophils have been shown to control lung pathology through
the release of suppressor cytokines such as IL-10 [23] and it is
possible that this granulocyte subset contributes to host survival
during virus infection by suppressing the cytokine storm induced in
the lung in response to infection. Our data show that Ly6G
+
granulocytes in the bone marrow of infected WT mice express
high levels of IL-10 in response to pro-inflammatory signals. This
response is abrogated in the absence of G-CSF, suggesting a
possible mechanism for the G-CSF-dependent suppressor activity.
Using an antibody-mediated neutrophil depletion model, a
series of recent reports have suggested a role for neutrophils during
infection with influenza virus [24,25,26,27,28]. G-CSF-deficient
mice provide a complementary method for the reduction of
functional granulocytes, confirming a critical role for these cells in
controlling lung pathology during infection with normally non-
lethal respiratory viruses. Interestingly, the effect of neutrophils in
lung pathology is influenced by the virus strain used (23),
suggesting that additional factors contribute to the overall effect
of granulocyte-mediated protection against viral infection.
Currently, G-CSF is used in the clinic for the treatment of BM
transplant recipients to aid in their recovery and to protect them
from bacterial infections. It may be beneficial to take a closer look
at individuals that suffer from severe virus infections and examine
the status of their neutrophil population. Is possible that during
certain infections, or under specific health conditions, G-CSF
treatment may promote quick virus clearance and recovery from
infection.
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